Pnc Financial Services Group, Inc. Design Therapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 9,251 shares of DSGN stock, worth $35,801. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,251
Previous 9,219
0.35%
Holding current value
$35,801
Previous $56,000
37.5%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding DSGN
# of Institutions
101Shares Held
33.4MCall Options Held
4KPut Options Held
3.1K-
Sr One Capital Management, LP6.53MShares$25.3 Million11.4% of portfolio
-
Logos Global Management LP San Francisco, CA4.22MShares$16.3 Million3.17% of portfolio
-
Black Rock Inc. New York, NY2.3MShares$8.92 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA1.95MShares$7.56 Million0.47% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct1.82MShares$7.04 Million0.02% of portfolio
About Design Therapeutics, Inc.
- Ticker DSGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,807,900
- Market Cap $216M
- Description
- Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...